Age-Related Macular Degeneration (AMD): Types, Symptoms, and Early Action

Epidemiology

Leading cause of irreversible central vision loss in adults >50 in developed nations. Prevalence rises sharply with age.

Two Forms

FeatureDry (Atrophic) AMDWet (Neovascular) AMD
Prevalence80–90%10–20%
PathologyDrusen, RPE atrophy, geographic atrophyChoroidal neovascularization (CNV) → leakage, hemorrhage
ProgressionGradual (years)Rapid (weeks–months)
Vision lossSlow, central scotomaSudden, severe distortion/loss

Symptoms

  • Central blurring, metamorphopsia (straight lines wavy)
  • Dark/empty central spot
  • Difficulty reading, recognizing faces, low-light vision

Management

  • Dry: AREDS2 supplements (vitamins C, E, lutein, zeaxanthin, zinc, copper) slow progression in intermediate/advanced unilateral. Lifestyle: smoking cessation, UV protection, cardiovascular health.
  • Wet: Anti-VEGF intravitreal injections (aflibercept, ranibizumab, faricimab, brolucizumab) – mainstay; monthly or treat-and-extend. Photodynamic therapy (rare).

Urgency

New distortion or vision drop → same-week ophthalmology. Early anti-VEGF preserves vision.

Eye & Vision Disorders - Related Articles